TC
BSX icon

Tenere Capital’s Boston Scientific BSX Stock Holding History

Tenere Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-174,067
Closed -$11.9M – 30
2024
Q1 		$11.9M Sell
174,067
-6,553
-4% -$421K 3.55% 14
2023
Q4 		$10.4M Buy
+180,620
New +$9.64M 3.41% 16
2023
Q3 		– Sell
-128,900
Closed -$6.97M – 28
2023
Q2 		$6.97M Buy
+128,900
New +$6.73M 3.42% 19

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Tenere Capital's BSX Position: Q2 2024 in Review

Tenere Capital sold out of Boston Scientific (BSX) in Q2 2024, closing a stake of 174,067 shares — an estimated $11.9M sold.

Tenere Capital first reported a position in BSX in Q2 2023 and held it in 3 quarters. The position peaked at $11.9M in Q1 2024. 1,321 funds tracked by Wall St. Rank hold BSX as of Q2 2024.

  • Tenere Capital reported no remaining Boston Scientific position as of Q2 2024 after selling out during the quarter.
  • Tenere Capital sold 174,067 Boston Scientific shares in Q2 2024, an estimated $11.9M.
  • Tenere Capital first reported a position in Boston Scientific in Q2 2023 and held it in 3 quarters.
  • Tenere Capital's Boston Scientific position peaked at $11.9M in Q1 2024.
  • 1,321 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2024.

Based on Tenere Capital's 13F filing for Q2 2024, filed 14 Aug 2024.